All Experts in Cancer

Editors

Dr. Soldano Ferrone
Harvard Medical School, USA
Prof. Carl-Henrik Heldin
Ludwig Institute of Cancer Research, Sweden
Prof. Yibin Kang
Princeton University, USA

Speakers

Dr. Janet Abrahm
Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, USA
Prof. Sam Ahmedzai
University of Sheffield, UK
Prof. Dario Alessi
University of Dundee, UK
Prof. Kari Alitalo
Molecular/Cancer Biology Laboratory, University of Helsinki, Finland
Dr. Krishna Allamneni
Concarlo Therapeutics, USA
Prof. James Allison
Memorial Sloan-Kettering Cancer Center, USA
Prof. Tejraj Aminabhavi
College of Pharmacy, India
Prof. Vladimir N. Anisimov
N.N. Petrov Research Institute of Oncology, Russia
Prof. Victor Appay
INSERM, France
Dr. Mark M. Awad
Dana-Farber Cancer Institute, USA
Prof. Anthony Axon
Leeds University Hospital, UK
Dr. Christina Baik
University of Washington School of Medicine, USA
Prof. Stephen Baylin
Sidney Kimmel Comprehensive Cancer Center, USA
Prof. Roderick Beijersbergen
Netherlands Cancer Institute, The Netherlands
Prof. Steve Belinsky
Lovelace Respiratory Research Institute, USA
Dr. Stacy Blain
SUNY Downstate Health Sciences University, USA
Dr. Andres Blanco
University of Pennsylvania, USA
Prof. Zeev Blumenfeld
Technion - Israel Institute of Technology, Israel
Prof. Sir Walter Bodmer
University of Oxford, UK
Prof. Randall Brand
University of Pittsburgh, USA
Prof. Peter Brennan
University of Portsmouth, UK
Prof. Bob Brown
Imperial College London, UK
Prof. David Brown
The University of Texas MD Anderson Cancer Center, USA
Prof. Jennifer R. Brown
Harvard Medical School, USA
Dr. Elizabeth Buchbinder
Harvard Medical School, USA
Prof. Fred Bunz
Johns Hopkins University, USA
Prof. Tony Burgess
Walter and Eliza Hall Institute, Australia
Prof. Carol A. Burke
Cleveland Clinic, USA
Prof. Sir John Burn
Newcastle University, UK
Prof. Allen Burton
The University of Texas MD Anderson Cancer Center, USA
Prof. Andrea Califano
Columbia University Medical Center, USA
Prof. George Calin
MD Anderson Cancer Center, USA
Prof. Daniel Carr
Tufts University School of Medicine and Javelin Pharmaceuticals, USA
Prof. Roberto Cattaneo
Mayo Clinic College of Medicine, USA
Dr. Guido Cavaletti
University of Milano-Bicocca, Italy
Dr. Gabriela Chiosis
Memorial Sloan-Kettering Cancer Center, USA
Prof. David Christiani
Harvard School of Public Health and Harvard Medical School, USA
Dr. Jeffrey Clark
Harvard Medical School, USA
Prof. Robert Clarke
Lombardi Comprehensive Cancer Center, Georgetown University, USA
Prof. Paolo Comoglio
Institute for Cancer Research and Treatment (IRCC), Italy
Prof. John P. Cooke
Houston Methodist Research Institute, USA
Dr. Antonello Covacci
Novartis Vaccines and Diagnostics, Italy
Dr. Rachel Cowie
University of Bristol, UK
Prof. Mark Cragg
University of Southampton, UK
Prof. José Cuezva
Universidad Autónoma de Madrid, Spain
Prof. James DeGregori
University of Colorado, USA
Prof. Michael W. Deininger
University of Utah, USA
Prof. Michele De Palma
San Raffaele Scientific Institute, Italy
Prof. Larry Driver
The University of Texas MD Anderson Cancer Center, USA
Prof. Brian Druker
Oregon Health & Science University Cancer Institute, USA
Prof. Joe Duffy
St Vincent's University Hospital and University College Dublin, Ireland
Dr. Scott Durum
National Cancer Institute, NIH, USA
Prof. Brian Dynlacht
New York University School of Medicine and NYU Cancer Institute, USA
Prof. Diana Eccles
University of Southampton, UK
Prof. Martin Edelman
Fox Chase Cancer Center, USA
Prof. Robert N. Eisenman
Fred Hutchinson Cancer Research Center, USA
Prof. Tim Elliott
University of Oxford, UK
Prof. Charis Eng
Cleveland Clinic, USA
Prof. Lynn W. Enquist
Princeton University, USA
Prof. Raymond Erikson
Harvard University, USA
Dr. Enrique Espinosa
Hospital La Paz, Spain
Prof. D. Gareth R. Evans
The University of Manchester, UK
Dr. Tracey Evans
University of Pennsylvania, USA
Dr. William Evans
St. Jude Children’s Research Hospital, USA
Prof. David Feldman
Stanford School of Medicine, USA
Prof. William Fenical
University of California San Diego, USA
Dr. Mauro Ferrari
Houston Methodist Hospital, USA
Dr. Soldano Ferrone
Harvard Medical School, USA
Dr. Giuseppe Ficarra
University of Florence and Azienda Ospedaliera, Italy
Prof. David E. Fisher
Massachusetts General Hospital, USA
Prof. Jude Fitzgibbon
University of London, UK
Dr. David Flockhart
Indiana University School of Medicine, USA
Dr. Joseph A. Fraietta
University of Pennsylvania, USA
Dr. Simone Fulda
University Children's Hospital Ulm, Germany
Prof. Dmitry Gabrilovich
AstraZeneca, USA
Prof. Rollin Gallagher
Philadelphia VA Medical Center and University of Pennsylvania, USA
Dr. Bob Gatenby
Moffitt Cancer Center, USA
Dr. Irene Ghobrial
Dana-Farber Cancer Institute, Harvard Medical School, USA
Dr. Larry Gold
SomaLogic, USA
Prof. Ramaswamy Govindan
Washington University in St. Louis, USA
Prof. Mel Greaves
Institute of Cancer Research, UK
Prof. Mark Greene
University of Pennsylvania, USA
Prof. Tim Greten
Senior Investigator, Bethesda, USA
Dr. Wenjun Guo
Albert Einstein College of Medicine, USA
Prof. J. Silvio Gutkind
University of California San Diego, USA
Prof. Grahame Hardie
University of Dundee, UK
Dr. Annick Harel-Bellan
Institut Andre Lwoff, France
Prof. Parameswaran Hari
Medical College of Wisconsin, USA
Prof. Kevin Harrington
The Institute of Cancer Research, UK
Dr. Tim Harris
Biogen Idec., USA
Dr. Vignir Helgason
University of Glasgow, UK
Prof. Fred Hirsch
University of Colorado Cancer Center, USA
Prof. Palle Holmstrup
University of Copenhagen, Denmark
Dr. Homa Homayoni
University of Texas, USA
Prof. Nancy Hynes
Friedrich Miescher Institute, Basel, Switzerland
Dr. Else Marit Inderberg
The Norwegian Radium Hospital, Norway
Prof. Gordon Irving
Swedish Pain and Headache Center and University of Washington, USA
Dr. Pasi Janne
Dana Faber Cancer Institute and Harvard Medical School, USA
Prof. Xuejun Jiang
Memorial Sloan Kettering Cancer Center, USA
Prof. V. Craig Jordan
The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA
Dr. Nicholas Kalavrezos
University College London Hospital, UK
Dr. Philipp Kaldis
Faculty of Medicine at Lund University, Sweden
Dr. Andrius Kazlauskas
Schepens Eye Research Institute, Harvard Medical School, USA
Prof. David Kerr
University of Oxford, UK
Prof. Tae Won Kim
Asan Medical Center, University of Ulsan, S. Korea
Prof. Sebastian Kobold
Ludwig-Maximilians-Universität München, Germany
Prof. Jill Kolesar
University of Kentucky, USA
Dr. Koorosh Korfi
Barts Cancer Institute, UK
Dr. Daniela Krause
Massachusetts General Hospital, USA
Prof. Siavash Kurdistani
University of California, Los Angeles, USA
Prof. Stephen Lam
University of British Columbia, Canada
Prof. Ola Landgren
Memorial Sloan Kettering Cancer Center, USA
Prof. Emeritus John D. Langdon
King’s College London, UK
Prof. Eric Legius
University of Leuven, Belgium
Prof. Michael Levin
Biology Department, TCRDB, Tufts University, USA
Dr. Frank I. Lin
National Cancer Institute, USA
Dr. W. Marston Linehan
National Institutes of Health, USA
Dr. Charles Loprinzi
Mayo Clinic, USA
Prof. Eamonn Maher
University of Cambridge, UK
Prof. Thomas Malek
University of Miami, USA
Prof. David Mankoff
University of Washington, USA
Prof. Alberto Mantovani
IRCCS Istituto Clinico Humanitas, Humanitas University, Italy
Prof. Richard Marais
The Institute of Cancer Research, UK
Prof. Maurie Markman
Cancer Treatment Centers of America, USA
Prof. Sharon Marsh
University of Alberta, Canada
Dr. Heather McArthur
UT Southwestern, USA
Prof. David McDermott
Harvard Medical School, USA
Prof. Cornelis Melief
Leiden University Medical Center, The Netherlands
Prof. Gerry Melino
University of Rome Tor Vergata, Italy and MRC Toxicology Unit, Leicester University, UK
Prof. Eline Menu
Vrije Universiteit Brussel, Belgium
Dr. Ruben A. Mesa
UT Health San Antonio Cancer Center, USA
Dr. Jochen Metzger
Mosaiques Diagnostics GmbH, Germany
Prof. Gordon B. Mills
MD Anderson Cancer Center, USA
Prof. Duane A. Mitchell
University of Florida, USA
Prof. Felix Mitelman
Lund University, Sweden
Prof. Gil Mor
Wayne State University, USA
Prof. João Nuno Moreira
University of Coimbra, Portugal
Prof. Randolph Nesse
University of Michigan, USA
Dr. Francesco Nicoli
Universities of Ferrara and Padua, Italy
Prof. Stephen Nimer
University of Miami Health Care, USA
Prof. Daniel Normolle
University of Pittsburgh, USA
Prof. Graham Ogden
University of Dundee, UK
Prof. Kutluk H. Oktay
Yale University School of Medicine, USA
Prof. Malini Olivo
National University of Ireland, Galway, Ireland
Prof. Bert H. O'Neil
IU Simon Cancer Center, Indiana, USA
Prof. Moshe Oren
The Weizmann Institute of Science, Israel
Prof. Judith Paice
Northwestern University, USA
Prof. Klaus Pantel
University Medical Center Hamburg-Eppendorf, Germany
Prof. Luis Pardo
Max Planck Institute for Multidisciplinary Sciences, Germany
Dr. Olivier Pardo
Imperial College London, UK
Dr. Sheetal Parida
Johns Hopkins Medicine, USA
Dr. Wendy Parulekar
Queen’s University, Canada
Dr. Thomas Paul
Director of Cancer Epigenetics, Pfizer, USA
Prof. Douglas E. Peterson
UConn Health, USA
Prof. Gerd Pfeifer
Beckman Research Institute, City of Hope Cancer Center, USA
Prof. Paul Pharoah
University of Cambridge, UK
Prof. Michael Pierce
University of Georgia, USA
Dr. Marco Pierotti
Istituto Nazionale per lo Studio e la Cura dei Tumori, Italy
Prof. Leonidas Platanias
Northwestern University Medical School, USA
Prof. Jeffrey Pollard
Albert Einstein College of Medicine, USA
Prof. Bhagwat Prasad
University of Washington, USA
Prof. Ching Hon Pui
St. Jude Children’s Hospital, USA
Dr. Bronislaw Pytowski
ImClone Systems, USA
Prof. Kanti Rai
Long Island Jewish Medical Center, USA
Dr. Susana C. Raimondi
St. Jude Children's Research Hospital, USA
Dr. Nitya Raj
Memorial Sloan Kettering Cancer Center, USA
Prof. Jon Raphael
Dudley Hospitals NHS Trust and Birmingham City University, UK
Dr. Md. David A. Reardon
Center for Neuro-Oncology Dana-Farber Cancer Institute, USA
Prof. Nishitha M. Reddy
Vanderbilt University Medical Center, USA
Dr. Jeremy Rees
National Hospital for Neurology and Neurosurgery, UK
Dr. Michael Retsky
Harvard TH Chan School of Public Health, USA
Dr. Theresa Reynolds
Department of Safety Assessment, Genentech, USA
Prof. Paul G. Richardson
Harvard Medical School, USA
Dr. Steven Richeimer
University of Southern California, USA
Prof. Caroline Robert
Institute Gustave Roussy, France
Prof. Neal Rosen
Memorial Sloan Kettering Cancer Center, USA
Prof. Martine Roussel
St. Jude Children’s Research Hospital, USA
Dr. Stephen J. Russell
CEO, Vyriad, USA
Prof. David Sabatini
Massachusetts Institute of Technology, USA
Dr. Michael Sawyer
University of Alberta, Canada
Prof. David T. Scadden
Harvard University, USA
Prof. Joshua Schiffman
University of Utah, USA
Dr. John Schiller
National Cancer Institute, USA
Dr. Birgit Schoeberl
Merrimack Pharmaceuticals, USA
Dr. Jonathan Schoenfeld
Harvard University, USA
Prof. James J. Sciubba
The Johns Hopkins School of Medicine, USA
Prof. Ben Seon
Roswell Park Cancer Institute, USA
Dr. Nilay Sethi
Dana-Farber Cancer Institute, USA
Prof. Leonard Seymour
University of Oxford, UK
Dr. Maitri Shah
MD Anderson Cancer Center, USA
Prof. Allen Shearn
Professor Emeritus, Johns Hopkins University, USA
Prof. Zhiyuan Shen
Rutgers Cancer Institute of New Jersey, USA
Dr. Ali Shilatifard
Stowers Institute, USA
Dr. Richard Siegel
NIAMS, National Institutes of Health-Bethesda, USA
Prof. Bruno Silva-Santos
University of Lisbon, Portugal
Dr. Vernon K. Sondak
H. Lee Moffitt Cancer Center and Research Institute, USA
Prof. Stephen T. Sonis
Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, USA
Dr. Mario Squadrito
San Raffaele Scientific Institute, Italy
Prof. Reiko Sugiura
Kindai University, Japan
Prof. Stephen Tait
University of Glasgow, UK
Dr. Patricia Tang
University of Calgary, Canada
Dr. Baraa Tayeb
King Abdulaziz University Faculty of Medicine, Saudi Arabia
Dr. Molly Taylor
AstraZeneca, UK
Prof. Thomas Tedder
Duke University Medical Center, USA
Prof. Michael Thun
American Cancer Society, USA
Dr. Marc Tischkowitz
University of Cambridge, UK
Dr. Sara M. Tolaney
Dana-Farber Cancer Institute and Harvard Medical School, USA
Prof. Maria Tomasz
Hunter College, City University of New York, USA
Prof. Naoto T. Ueno
The University of Texas MD Anderson Cancer Center, USA
Dr. Olaf van Tellingen
The Netherlands Cancer Institute, The Netherlands
Dr. Sharad K. Verma
GlaxoSmithKline, USA
Prof. Paula Vertino
Emory University, USA
Dr. Alessandro Villa
Harvard University, USA
Prof. Antonia Vlahou
Bioacademy, Greece
Prof. Thomas Waldmann
Metabolism Branch, National Cancer Institute, National Institutes of Health, USA
Prof. Christine M. Walko
H. Lee Moffitt Cancer Center, Tampa, USA
Prof. Carsten Watzl
Leibniz Research Centre for Working Environment and Human Factors, Germany
Prof. Robert Weinberg
Whitehead Institute for Biomedical Research, USA
Prof. Robin Weiss
University College London, UK
Prof. Jeffrey Weitzel
City of Hope, USA
Dr. Piri Welcsh
University of Washington, USA
Prof. JoEllen Welsh
University of Notre Dame, USA
Prof. Michael Wendt
Purdue University, USA
Prof. Elizabeth Wilson
University of North Carolina at Chapel Hill, USA
Prof. Isaac P. Witz
Tel Aviv University, Israel
Prof. Dieter Wolf
Sanford Burnham Prebys Medical Discovery Institute, USA
Dr. Sook-Bin Woo
Harvard School of Dental Medicine, USA
Dr. Theodore Yaeger
Wake Forest University, USA
Dr. Michael Yaffe
Massachusetts Institute of Technology, USA
Dr. Hai Yan
Duke University School of Medicine, USA
Dr. Allen Yang
Amgen Inc. USA
Prof. Jing Yang
University of California San Diego, USA
Dr. Tim Yen
Fox Chase Cancer Center, Philadelphia, USA
Prof. Robert Zorec
University of Ljubljana, Slovenia